On 13 October 2016 Diederik Schrijvershof spoke about the (im)possibilities for joint purchasing of expensive prescription drugs at the congress Consequences for transparency by add-on registration in 2017, organised by MEI Zakelijke Bijeenkomsten.
Read more >